AlphaGrep UK’s Crocs CROX Stock Holding History

AlphaGrep UK’s Portfolio CROX Stock Details CROX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,893	Closed	-$240K	–	779
2026 Q1	$240K	Buy	2,893 +92	+3%	+$7.88K	0.07%	616
2025 Q4	$240K	Buy	+2,801	New	+$234K	0.08%	551

Other funds holding CROX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

AlphaGrep UK's CROX Position: Q2 2026 in Review

AlphaGrep UK sold out of Crocs (CROX) in Q2 2026, closing a stake of 2,893 shares — an estimated $240K sold.

AlphaGrep UK first reported a position in CROX in Q4 2025 and held it in 2 quarters. The position peaked at $240K in Q1 2026. 465 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

AlphaGrep UK reported no remaining Crocs position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 2,893 Crocs shares in Q2 2026, an estimated $240K.
AlphaGrep UK first reported a position in Crocs in Q4 2025 and held it in 2 quarters.
AlphaGrep UK's Crocs position peaked at $240K in Q1 2026.
465 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.